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An inﬂuenza vaccination often causes local reactions, such as induration and erythema at the injection
site, and occasionally systemic reactions. The association between these reactions and inﬂuenza vacci-
nations has not been fully recognized. By contrast, granuloma annulare (GA) is an idiopathic, palisaded,
granulomatous condition, and has some clinical variants, including localized, generalized, perforating,
and subcutaneous types. We report a 76-year-old woman, who was suffering from a tender subcutaneous
nodule on her left upper arm. One month before, she had just received inﬂuenza vaccination on the same
area. Histological analysis demonstrated that subcutaneous tissue contained numerous large areas of
necrosis, surrounded by palisaded epithelioid histiocytes. We diagnosed our case as a subcutaneous type
of GA following inﬂuenza vaccination. To our knowledge, this is the ﬁrst report of GA associated with
inﬂuenza vaccination.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Inﬂuenza vaccination often causes local reactions, such as indura-
tion and erythema at the injection site, and occasionally systemic
reactions.1 Despite the high incidence of the skin reactions, the
histopathology of the reactions remains not fully characterized.
Granuloma annulare (GA) is an idiopathic, palisaded, granulo-
matous condition and has several clinical variants, including
localized, generalized, perforating, and subcutaneous types.2,3
Here, we report a case of subcutaneous GA arising at the site
where an inﬂuenza vaccination was injected.
Case report
A 76-year-old woman was referred to us for evaluation of a
1-month history of a tender subcutaneous nodule on her left upper
arm. One month before, she had received an inﬂuenza vaccination
on the same site. She had suffered from hypertension and diabetes
mellitus. There was no history of egg allergy. On physical exami-
nation, a 6  6 mm tender, solid subcutaneous nodule was seen on
the outer aspect of her left upper arm (Figure 1A). Magnetice no ﬁnancial or non-ﬁnancial
erials discussed in this article.
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cutaneous fat tissue overlying the superﬁcial fascia (Figure 1B).
Histological analysis of the totally excised nodule demonstrated
a globular, well-demarcated, cell-inﬁltrating lesion in the subcu-
taneous fat (Figure 1C). The nodule contained a central necrotic
area with irregular conﬁguration. The abundant epithelioid his-
tiocytes surrounded the foci of necrosis in a palisading manner
(Figure 1D). No organisms could be detected by Ziel-Neelsen stain.
We diagnosed the lesion as the subcutaneous type of GA following
an inﬂuenza vaccination.
Discussion
It is well known that GA is occasionally associated with diabetes
mellitus. Thus, she had a predisposing factor for GA. In this patient,
however, there was no GA lesion before the inﬂuenza vaccination,
and GA occurred only at the site of vaccination. After the resection
of GA, there was no recurrence on either the same site or other
sites. Therefore, it is tempting to speculate that diabetes mellitus
served as a predisposing factor for GA and vaccination directly
triggered GA in our patient. We reviewed the previous reports
describing GA following vaccinations; 11 cases have been reported
(Table 1).4e12 The types of vaccinations included those against
hepatitis B virus, Bacillus Calmette-Guerin (BCG), human papilloma
virus, diphtheria, and tetanus. To the best of our knowledge, our
case is the ﬁrst report of GA associated with inﬂuenza vaccinations.
Only three cases, including our case, were the subcutaneous type. Inn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) Clinical appearance of the subcutaneous nodule in the patient’s left upper arm; (B) magnetic resonance imaging with T1-weighted image. The white arrow shows the
subcutaneous nodule; (C) histological ﬁndings, low-power view, showing a large area of necrosis surrounded by inﬂammatory cells (hematoxylin-eosin, original magniﬁcation 20);
(D) high-power view, showing abundant histiocytes arranged in sheets surrounding the central foci of necrosis (hematoxylin-eosin, original magniﬁcation 100).
Table 1 GA following vaccinations.
Case Age/sex Type of vaccinations Type of GA Duration of onset
following vaccination
Location Treatment Authors, year (Reference)
1 51 y/F HBV Generalized 1 month Non-injection site DDS Wolf F et al, 19984
2 5 m/M BCG Generalized 1 month Non-injection site Moisturization Nagase K et al, 20115
3 52 y/F BCG Localized 30 years Injection site INH þ PSL Middelburg TA e al, 20096
4 26 y/F HPV (aluminum adjuvants) Subcutaneous 1 month Injection site Excision Marsee DK et al, 20087
5 8 y/F Diphtheria Generalized 1 week Injection site Topical or oral steroid Baskan EB et al, 20058
6 58 y/F HBV Generalized 2 months Non-injection site Corticosteroid ointment Criado PR et al, 200499
7 6 y/F Tetanus Localized 2 months, 3 days Non-injection site Corticosteroid ointment Baykal C et al, 200210
8 12 y/M BCG Generalized 5 days Non-injection site Corticosteroid ointment Kakurai M et al, 200111
9 3 y/M BCG Generalized 1 month Injection site No treatment Houche-Bruge C et al, 200112
10 3 y/M BCG Generalized 1 month Injection site? No treatment Houche-Bruge C et al, 200112
11 2 y/F BCG Subcutaneous 2 month Non-injection site No treatment Houche-Bruge C et al, 200112
Our case 76 y/F Inﬂuenza Subcutaneous 1 month Injection site Excision Present article
GA ¼ granuloma annulare; y ¼ years; m ¼ month; HBV ¼ hepatitis B virus; BCG ¼ Bacillus Calmette-Guerin; HPV ¼ human papilloma virus.
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and the GA onset was within 2 months. The patients were often
treated with topical corticosteroids or excision, or untreated.
Although one reported case suggested the relationship between
an adjuvant and development of subcutaneous GA,7 it remains
unknown whether GA was triggered by vaccines per se or by ad-
juvants. Since the initial use of adjuvants in the 1920s, aluminum
salts had been the most common adjuvant for vaccine formula-
tions.7 However, current inﬂuenza vaccinations in Japan do not
include the aluminum adjuvants. This raises the possibility that our
patient’s GAwas caused by a speciﬁc vaccine antigen. It is suggested
that vaccine antigen may evoke a T cell-mediated, granuloma-inducing immune reaction in predisposed individuals. Given that
our patient had diabetes mellitus, a disease potentially promoting
granuloma formation, such as necrobiosis lipoidica and GA, she
might be susceptible to vaccine-induced GA.References
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